By Regulatory Approvals — FDA clears Roche's Enspryng as first at-home therapy for thyroid eye disease FirstWord Pharma
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 16, 2026.